Stock Market
Equity markets in India and the US: Sensex, Nifty, Wall Street indices, IPOs and the corporate news that moves stocks.
Latest Stock Market stories
BLAIZE HOLDINGS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Blaize Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BZAI
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blaize Holdings, Inc. (NASDAQ: BZAI) between July 18, 2025 and April 28, 2026, both dates inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. (“Cooper” or the “Company”) (NASDAQ: COO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
GE HealthCare announces cash dividend increase for third quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical dia
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership e...
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a conference call the following morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discus...
Canadian Stocks Up A Second Straight Day
Bay Street was up again on Tuesday, extending Monday's gains as it touched a fresh two-week closing high. The benchmark S&P/TSX Composite Index opened higher and continued to trend to the upside throughout the trading day before easing just before the close.
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug DeliveryTM (PEDDTM) Portfolio for Liver Embolization
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard-of-care therapies and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for TriNav® Advance, the newest addition to its Pressure-Enabled Drug DeliveryTM (PEDD) portfolio. TriNav® Advance expands Tri
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformation.“Pascal is a highly respected executive and accomplished financial leader whose
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a conference call the following morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended yo
PNR DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pentair Plc Investors To Secure Counsel Before Important October 2 Deadline In Securities Class Action - PNR
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of Pentair plc (NYSE: ...
Cloudera Named A Leader In The 2026 IDC Marketscape For Asia/Pacific Sovereign AI Platforms
(MENAFN - GlobeNewsWire - Nasdaq) SAN JOSE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Cloudera, the only company bringing AI to data anywhere, today announced it has been named a Leader in the IDC ...
Vivosim Labs Inc. (NASDAQ: VIVS) Uses Human 3D Biology To Streamline Drug Development
(MENAFN - GetNews) United States - Sept. 22, 2026 - VivoSim Labs Inc. (NASDAQ: VIVS) is using engineered human tissues to provide pharmaceutical researchers with earlier and potentially more ...
Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
Tech Stocks Rose As Trump Played Down New AI Rules
Investors cheered chipmakers while Alibaba launched a new AI chip and OpenAI and Anthropic lined up for a UN Security Council briefing.
MAGS: Top Magnificent 7 ETF inflows surge as Meta, AAPL stocks surge
The Roundhill Magnificent Seven ETF (MAGS) is firing on all cylinders, as top constituents gains, including Meta Platforms (META) and Apple (AAPL) surge. MAGS ETF jumped to a record high of $73.47, up by over 32% from its lowest level this year. The MAGS ETF is doing well, held by the ongoing Meta Platforms stock soared. Data shows that the fund added over $43 million in inflows on September 18, bringing the 30-day inflows to over $182 million. The fund holds over $357 million this year, bringin
US Consumer Stocks Rose As Redbook Flagged Soft Traffic
Same-store sales were up 7.6% year-on-year in the week ended Sept. 19, even as Redbook pointed to light traffic and warmer weather weighing on apparel.
Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development
PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in real-world evidence (RWE) generation from high-quality healthcare data, today announced a significant expansion of its federated Atropos EvidenceTM Network. The expansion includes deeper collaborations with Norstella and Arcadia, along with new data partnership agreements with OneMedNet Corporation (Nasdaq: ONMD). These alliances extend the scope of Atropos Health’s data ecosystem across clinical decision support (CDS), model traini
Reviewing Elemental Royalty (ELE) and The Competition
Elemental Royalty (NASDAQ:ELE – Get Free Report) is one of 1,987 public companies in the “Metals & Mining” industry, but how does it compare to its competitors? We will compare Elemental Royalty to similar companies based on the strength of its valuation, institutional ownership, earnings, dividends, profitability, analyst recommendations and risk. Analyst Recommendations This is [...]
Bill Ackman ditches a major AI stock after just one quarter
One of Wall Street’s highest-profile hedge fund managers held a major technology position for barely three months before selling it. Bill Ackman, Founder and Chief Executive Officer of Pershing Square Capital Management, bought Alphabet shares in the first quarter and sold all by June 2026. The...
Best Biotech Stocks To Consider – September 22nd
Moderna, Viking Therapeutics, and Amgen are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies that develop or commercialize biological products, such as medicines, vaccines, diagnostics, and gene or cell therapies. For investors, these stocks can offer significant growth potential but often carry [...]
How Info60 covers this topic
Each story below is a short excerpt from reporting by an established publisher, shown in the publisher's own words. We credit the publisher and link to the original article. Stories are matched to this topic by keyword and shown newest first.